Stem Cell Blog
The uses of umbilical cord stem cells are rapidly increasing. Ten years ago, cord blood could treat about 40 conditions but today, that number is now over 80. As we look forward to new therapies for diseases and disorders like diabetes, autism and stroke, you can keep up to date with the latest developments in regenerative medicine on our stem cell blog.
Stem Cell Blog
The uses of umbilical cord stem cells are rapidly increasing. Ten years ago, cord blood could treat about 40 conditions but today, that number is now over 80. As we look forward to new therapies for diseases and disorders like diabetes, autism and stroke, you can keep up to date with the latest developments in regenerative medicine on our stem cell blog.
The Race for a Cure: an oral COVID-19 vaccine
Last week, Cells4Life's sister company, Stabilitech, featured on ITV's Tonight programme "The Race for a Cure: Making Britain Safer". This episode looks at making a COVID-19 vaccine. You can watch the full interview by watching the video below. Request a Welcome Pack...
“How cord tissue changed my son’s life”
A 5-year-old boy with Autism Spectrum Disorder (ASD) has made significant progress after receiving stem cell therapy using umbilical cord tissue. Gage was diagnosed with ASD at just two years old after there were some indications that there may be a problem –...
WHO recognises Cells4Life sister company, Stabilitech, as a COVID-19 vaccine developer
The sister company of Cells4Life, Stabilitech Biopharma, have been formally recognised by the World Health Organisation (WHO) as an official vaccine developer. Stabilitech board member Dr Jeff Drew, who is also the co-founder of Cells4Life, noted: “The WHO is a...
Pregnant women at no greater risk of developing severe COVID-19, study reveals
According to the first large-scale study of its kind, pregnant women are at no greater risk of being admitted to hospital with severe coronavirus symptoms than other women. The study examined more than 420 expectant mothers who were admitted to hospital with critical...
Cells4Life sister company, Stabilitech, joins race for COVID-19 vaccine
The sister company of Cells4Life – Stabilitech – has joined the race to create a vaccine for the coronavirus which has put the country into lockdown and is currently raising £6 million in funding to finance the next crucial stage of development.Stabilitech, a UK...
Recent Posts
-
The Race for a Cure: an oral COVID-19 vaccine - “How cord tissue changed my son’s life”
- WHO recognises Cells4Life sister company, Stabilitech, as a COVID-19 vaccine developer
- Pregnant women at no greater risk of developing severe COVID-19, study reveals
- Cells4Life sister company, Stabilitech, joins race for COVID-19 vaccine
Find out more, request your welcome pack today
Find out more, request your welcome pack today
